InflaRx (IFRX) Operating Expenses (2016 - 2026)

InflaRx has disclosed Operating Expenses across 11 years of filings, most recently posting -$8.5 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 34.64% year-over-year to -$8.5 million; the TTM figure through Jun 2026 stood at -$38.0 million (up 60.47% YoY), while the FY2025 annual figure was -$44.3 million, up 14.36% from the prior year.
• Operating Expenses came in at -$8.5 million for Q2 2026 at InflaRx, up from -$8.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$8.5 million in Q2 2026 to a low of -$53456.5 billion in Q4 2022.
• Average Operating Expenses over 5 years is -$2969.8 billion, with a median of -$14.3 million recorded in 2024.
• Year-over-year, Operating Expenses plunged 74.37% in 2022 and surged 100.0% in 2023.
• Over 5 years, Operating Expenses stood at -$53456.5 billion in 2022, then jumped by 100.0% to -$57.7 million in 2023, then increased by 10.43% to -$51.7 million in 2024, then soared by 82.5% to -$9.1 million in 2025, then gained by 6.02% to -$8.5 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were -$8.5 million in Q2 2026, -$8.7 million in Q1 2026, and -$9.1 million in Q4 2025.